These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 20006892)

  • 1. HBsAg-vectored vaccines simultaneously deliver CTL responses to protective epitopes from multiple viral pathogens.
    Chen D; Edgtton K; Gould A; Guo H; Mather M; Haigh O; Cochrane M; Kattenbelt J; Thomson S; Tindle R
    Virology; 2010 Mar; 398(1):68-78. PubMed ID: 20006892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B surface antigen vector delivers protective cytotoxic T-lymphocyte responses to disease-relevant foreign epitopes.
    Woo WP; Doan T; Herd KA; Netter HJ; Tindle RW
    J Virol; 2006 Apr; 80(8):3975-84. PubMed ID: 16571814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple copies of a tumor epitope in a recombinant hepatitis B surface antigen (HBsAg) vaccine enhance CTL responses, but not tumor protection.
    Haigh O; Guo H; Edgtton K; Mather M; Herd KA; Tindle RW
    Virology; 2007 Nov; 368(2):363-75. PubMed ID: 17689584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Priming MHC-I-restricted cytotoxic T lymphocyte responses to exogenous hepatitis B surface antigen is CD4+ T cell dependent.
    Wild J; Grusby MJ; Schirmbeck R; Reimann J
    J Immunol; 1999 Aug; 163(4):1880-7. PubMed ID: 10438922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancing the immunogenicity of exogenous hepatitis B surface antigen-based vaccines for MHC-I-restricted T cells.
    Schirmbeck R; Reimann J
    Biol Chem; 1999 Mar; 380(3):285-91. PubMed ID: 10223330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic cell immunization breaks cytotoxic T lymphocyte tolerance in hepatitis B virus transgenic mice.
    Shimizu Y; Guidotti LG; Fowler P; Chisari FV
    J Immunol; 1998 Nov; 161(9):4520-9. PubMed ID: 9794377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Construction of eukaryotic expression plasmids inserting HBsAg gene and DNA immunization responses to HBsAg in mice].
    Liang Z; Lan Y; Li Y; Cai D; Ren H
    Zhonghua Gan Zang Bing Za Zhi; 2002 Apr; 10(2):106-8. PubMed ID: 11983125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fusion of HBsAg and prime/boosting augment Th1 and CTL responses to HCV polytope DNA vaccine.
    Memarnejadian A; Roohvand F
    Cell Immunol; 2010; 261(2):93-8. PubMed ID: 20056196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilization of MHC class I transgenic mice for development of minigene DNA vaccines encoding multiple HLA-restricted CTL epitopes.
    Ishioka GY; Fikes J; Hermanson G; Livingston B; Crimi C; Qin M; del Guercio MF; Oseroff C; Dahlberg C; Alexander J; Chesnut RW; Sette A
    J Immunol; 1999 Apr; 162(7):3915-25. PubMed ID: 10201910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection.
    Nayersina R; Fowler P; Guilhot S; Missale G; Cerny A; Schlicht HJ; Vitiello A; Chesnut R; Person JL; Redeker AG; Chisari FV
    J Immunol; 1993 May; 150(10):4659-71. PubMed ID: 7683326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of Tc1 response and enhanced cytotoxic T lymphocyte activity in mice by dendritic cells transduced with adenovirus expressing HBsAg.
    Huang Y; Chen Z; Jia H; Wu W; Zhong S; Zhou C
    Clin Immunol; 2006 Jun; 119(3):280-90. PubMed ID: 16531121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of pre-existing cytotoxic T lymphocytes on therapeutic vaccines.
    Sherritt MA; Gardner J; Elliott SL; Schmidt C; Purdie D; Deliyannis G; Heath WR; Suhrbier A
    Eur J Immunol; 2000 Feb; 30(2):671-7. PubMed ID: 10671225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delivery of multiple CD8 cytotoxic T cell epitopes by DNA vaccination.
    Thomson SA; Sherritt MA; Medveczky J; Elliott SL; Moss DJ; Fernando GJ; Brown LE; Suhrbier A
    J Immunol; 1998 Feb; 160(4):1717-23. PubMed ID: 9469429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A single dose of oral DNA immunization delivered by attenuated Salmonella typhimurium down-regulates transgene expression in HBsAg transgenic mice.
    Zheng BJ; Ng MH; Chan KW; Tam S; Woo PC; Ng SP; Yuen KY
    Eur J Immunol; 2002 Nov; 32(11):3294-304. PubMed ID: 12555675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-capacity adenoviral vectors circumvent the limitations of ΔE1 and ΔE1/ΔE3 adenovirus vectors to induce multispecific transgene product-directed CD8 T-cell responses.
    Kron MW; Engler T; Schmidt E; Schirmbeck R; Kochanek S; Kreppel F
    J Gene Med; 2011 Dec; 13(12):648-57. PubMed ID: 22095925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term humoral and cellular immunity induced by a single immunization with replication-defective adenovirus recombinant vector.
    Juillard V; Villefroy P; Godfrin D; Pavirani A; Venet A; Guillet JG
    Eur J Immunol; 1995 Dec; 25(12):3467-73. PubMed ID: 8566039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant Kunjin virus replicon vaccines induce protective T-cell immunity against human papillomavirus 16 E7-expressing tumour.
    Herd KA; Harvey T; Khromykh AA; Tindle RW
    Virology; 2004 Feb; 319(2):237-48. PubMed ID: 14980484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant polyepitope vaccines for the delivery of multiple CD8 cytotoxic T cell epitopes.
    Thomson SA; Elliott SL; Sherritt MA; Sproat KW; Coupar BE; Scalzo AA; Forbes CA; Ladhams AM; Mo XY; Tripp RA; Doherty PC; Moss DJ; Suhrbier A
    J Immunol; 1996 Jul; 157(2):822-6. PubMed ID: 8752934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA immunization with 2C FMDV non-structural protein reveals the presence of an immunodominant CD8+, CTL epitope for Balb/c mice.
    Barfoed AM; Rodriguez F; Therrien D; Borrego B; Sobrino F; Kamstrup S
    Antiviral Res; 2006 Dec; 72(3):178-89. PubMed ID: 16890298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prime-boost vaccination using recombinant Mycobacterium bovis BCG and recombinant vaccinia virus DIs harboring HIV-1 CRF01_AE gag in mice: influence of immunization routes.
    Promkhatkaew D; Matsuo K; Pinyosukhee N; Thongdeejaroen W; Leang-Aramgul P; Sawanpanyalert P; Warachit P
    Southeast Asian J Trop Med Public Health; 2009 Mar; 40(2):273-81. PubMed ID: 19323012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.